As of 2025-09-18, the Fair Value of ALX Oncology Holdings Inc (ALXO) is -10.88 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.05 USD, the upside of ALX Oncology Holdings Inc is -1,136.62%.
With the market price of 1.05 USD and our fair value calculation, ALX Oncology Holdings Inc (ALXO) is not a good investment. Investing in ALXO stocks now will result in a potential loss of 1,136.62%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -45.74 | -83.46 | -123.48 | -161.00 | -135.00 | -109.74 |
| YoY growth | -137.73% | -82.47% | -47.95% | -30.39% | 16.15% | -56.48% |
| Market Cap (mil) | 56.23 |
| P/E | |
| Forward P/E |
| EPS | -2.18 |
| Avg earnings growth rate | -56.48% |
| TTM earnings | -116.57 |